Your browser doesn't support javascript.
loading
Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures.
Zanwar, Saurabh; Gertz, Morie A; Muchtar, Eli; Buadi, Francis K; Kourelis, Taxiarchis; Gonsalves, Wilson; Go, Ronald S; Hayman, Suzanne; Kapoor, Prashant; Binder, Moritz; Cook, Joselle; Dingli, David; Leung, Nelson; Lin, Yi; Warsame, Rahma; Fonder, Amie; Hobbs, Miriam; Hwa, Yi Lisa; Kyle, Robert A; Rajkumar, S Vincent; Kumar, Shaji; Dispenzieri, Angela.
Afiliação
  • Zanwar S; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Muchtar E; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Buadi FK; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Kourelis T; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Gonsalves W; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Go RS; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Hayman S; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Binder M; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Cook J; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Dingli D; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Leung N; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Warsame R; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Fonder A; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Hobbs M; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Hwa YL; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Kyle RA; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Kumar S; Division of Hematology, Mayo Clinic, Rochester, MN, US.
  • Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN, US. dispenzieri.angela@mayo.edu.
Leukemia ; 38(6): 1423-1426, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38594348
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Ciclofosfamida / Bortezomib / Amiloidose de Cadeia Leve de Imunoglobulina / Anticorpos Monoclonais Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Ciclofosfamida / Bortezomib / Amiloidose de Cadeia Leve de Imunoglobulina / Anticorpos Monoclonais Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de publicação: Reino Unido